TREM2 and early-onset autosomal dominant Alzheimer disease: Ruganzu et al. reported that TREM2 was involved in the cognitive decline of Alzheimer’s disease by influencing microglia proliferation and loss of neurons and synapse-related proteins, and interfering with neuroinflammatory reaction through MAPK signaling pathway mediated by TLR4 [30].